Australia markets closed

AN2 Therapeutics, Inc. (ANTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.27000.0000 (0.00%)
At close: 04:00PM EDT
2.2501 -0.02 (-0.88%)
After hours: 05:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
57,541
54,871
29,511
16,906
6,019
Selling general and administrative
14,351
14,764
12,751
4,668
1,265
Total operating expenses
71,892
69,635
42,262
21,574
7,284
Operating income or loss
-71,892
-69,635
-42,262
-21,574
-7,284
Total other income/expenses net
5,866
4,903
1,306
-38
-6,322
Income before tax
-66,026
-64,732
-40,956
-21,543
-13,603
Income from continuing operations
-66,026
-64,732
-40,956
-21,543
-13,603
Net income
-66,026
-64,732
-40,956
-21,543
-13,603
Net income available to common shareholders
-66,026
-64,732
-42,776
-28,058
-13,603
Basic EPS
-2.80
-2.74
-2.79
-1.55
-0.97
Diluted EPS
-2.80
-2.74
-2.79
-1.55
-0.97
Basic average shares
20,999
23,600
15,340
18,140
14,048
Diluted average shares
20,999
23,600
15,340
18,140
14,048